These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1689520)
61. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells. Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531 [TBL] [Abstract][Full Text] [Related]
62. The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506. Li PK; Nicholls MG; Lai KN Adverse Drug React Acute Poisoning Rev; 1990; 9(3):123-55. PubMed ID: 1703724 [No Abstract] [Full Text] [Related]
63. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells. Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900 [TBL] [Abstract][Full Text] [Related]
64. The immunosuppressive properties of new oral prostaglandin E1 analogs. Pollak R; Dumble LJ; Wiederkehr JC; Maddux MS; Moran M Transplantation; 1990 Nov; 50(5):834-8. PubMed ID: 2146785 [TBL] [Abstract][Full Text] [Related]
65. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients. Yoshimura N; Kahan BD Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806 [TBL] [Abstract][Full Text] [Related]
66. Lymphocyte activation mechanisms and in vitro actions of immunosuppressive drugs: a comparison. Dupont E; Denys C; Schandene L; Pereleux A; Romasco F; Wybran J Transplant Proc; 1987 Feb; 19(1 Pt 2):1227-9. PubMed ID: 3152625 [No Abstract] [Full Text] [Related]
67. Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil. Miroux C; Morales O; Ouaguia L; Aoudjehane L; Boleslawski E; Pancré V; de Launoit Y; Calmus Y; Conti F; Delhem N Transplant Proc; 2012 Nov; 44(9):2834-9. PubMed ID: 23146536 [TBL] [Abstract][Full Text] [Related]
68. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice. Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187 [TBL] [Abstract][Full Text] [Related]
69. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572 [TBL] [Abstract][Full Text] [Related]
70. Selective suppression of an early step in human B cell activation by cyclosporin A. Muraguchi A; Butler JL; Kehrl JH; Falkoff RJ; Fauci AS J Exp Med; 1983 Sep; 158(3):690-702. PubMed ID: 6193229 [TBL] [Abstract][Full Text] [Related]
71. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites. Copeland KR; Yatscoff RW; Rush D; Jeffery JR Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585 [No Abstract] [Full Text] [Related]
72. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture. Freed BM; Rosano TG; Quick C; Lempert N Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629 [No Abstract] [Full Text] [Related]
73. Potent and selective inhibition of in vitro lymphocyte migration by cyclosporine and dexamethasone. Ross JS; Bacon KB; Camp RD Immunopharmacol Immunotoxicol; 1990; 12(3):439-55. PubMed ID: 2176229 [TBL] [Abstract][Full Text] [Related]
74. Inhibition of PHA induced mononuclear cell proliferation by FK506 in combination with cyclosporine, methylprednisolone, 6-mercaptopurine and mycophenolic acid. Hibbins M; Inutsuka S; Chapman JR Transpl Immunol; 1993; 1(1):66-71. PubMed ID: 7521736 [TBL] [Abstract][Full Text] [Related]
76. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353 [TBL] [Abstract][Full Text] [Related]
77. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat. Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165 [TBL] [Abstract][Full Text] [Related]
78. S. aureus-induced B cell proliferation as a model for studying the effectiveness of immunosuppressive agents. Górski A; Wasik M Arch Immunol Ther Exp (Warsz); 1987; 35(5):651-5. PubMed ID: 3502685 [TBL] [Abstract][Full Text] [Related]
79. Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli. Furue M; Ishibashi Y Transplantation; 1991 Sep; 52(3):522-6. PubMed ID: 1654606 [TBL] [Abstract][Full Text] [Related]
80. In vitro immunosuppressive effect of deoxymethylspergualin. Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]